Why is "Cholangiocarcinoma" trending?

Search Interest Perspective

• OncLive Weekly News Quiz (4/3/2026): Are You Caught Up on Key Updates in MCL, Cholangiocarcinoma, and More? - OncLive
• FDA Grants Lirafugratinib Priority Review in FGFR2-Altered Cholangiocarcinoma - Targeted Oncology
• Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target - Nature
• Gene signature maps cholangiocarcinoma subtypes for precision treatment - News-Medical
• Wife of cholangiocarcinoma patient makes gift in honor of husband - Vanderbilt Health News
• Cholangiocarcinoma: Treatment, Genomics and Supportive Care - Cure Today
• FDA Grants Orphan Drug Designation to Zenocutuzumab in Cholangiocarcinoma - CancerNetwork
• Lirafugratinib Produces Durable Responses in FGFR2 Fusion Cholangiocarcinoma Trial - Oncology News Central
• City of Springfield and Jeffrey Speller Foundation join in recognizing Cholangiocarcinoma Awareness Month - springfield-ma.gov
• Distal Cholangiocarcinoma Diagnosed via Percutaneous SpyGlass Cholangioscopy After Failed Endoscopic Retrograde Cholangiopancreatography (ERCP) in a Patient With Suspected Gallstone Pancreatitis - Cureus
• Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma - PR Newswire
• FDA Grants Priority Review to Lirafugratinib for FGFR2+ Pretreated Cholangiocarcinoma - OncLive
• Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial - Nature
• Novel TROP2-Targeting ADC Gains FDA Orphan Drug Status in Cholangiocarcinoma - Targeted Oncology
• Intraductal Papillary Neoplasm With Associated Invasive Cholangiocarcinoma and Biliary Intraepithelial Neoplasia in Primary Sclerosing Cholangitis: A Case Report - Cureus
• Profiling ADC targets in cholangiocarcinoma: implications for therapeutic development - Nature
• The OncFive: Top Oncology Articles for the Week of 3/29 - OncLive
• Amino acid metabolic reprogramming: future prospects for cholangiocarcinoma therapy - Nature
• Cryoablation induces abscopal immunity in intrahepatic cholangiocarcinoma - Nature
• Identification of serum peptide biomarkers for cholangiocarcinoma diagnosis and staging via MALDI-TOF MS and LC-MS/MS - Nature
• Lirafugratinib NDA Seeks FDA Approval in Cholangiocarcinoma - Targeted Oncology
• Bile Duct Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
• Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial - The Lancet
• February: Cholangiocarcinoma Awareness Month - Hospital Clínic Barcelona
• Circulating Tumor DNA in Cholangiocarcinoma: A Precision Oncology Roadmap - Dove Medical Press
• Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat - Nature
• Microbial dysbiosis in cholangiocarcinoma - Frontiers
• IgG4-sclerosing cholangitis masquerading as cholangiocarcinoma: a case report of an unresolved preoperative diagnosis - Frontiers
• FDA Grants Orphan Drug Designation to OBI-902 in Cholangiocarcinoma - OncLive
• VIRMA/IGF2BP3-mediated ANLN upregulation promotes intrahepatic cholangiocarcinoma growth by forming a positive feedback loop with RhoA/YAP1/TEAD1 signaling pathway - Nature
• Advances in surgery for cholangiocarcinoma: Overcoming risks and expanding treatment options - mayoclinic.org
• Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response - Nature
• Zenocutuzumab Potential Explored in NRG1 -Positive Cholangiocarcinoma - The ASCO Post
• Lirafugratinib Seeks FDA Approval in Second Line for FGFR2-Altered Cholangiocarcinoma - OncLive
• FDA Grants BTD to Zenocutuzumab in NRG1+ Cholangiocarcinoma - CancerNetwork
• Establishment of novel cholangiocarcinoma cell lines with ARID1A deficiency and preclinical validation of synthetic lethality therapies - Nature
• MBNL3 regulates tumor progression and metastasis in cholangiocarcinoma and serves as a prognostic biomarker - Nature
• Intrahepatic Cholangiocarcinoma With Rare Metastasis Locations in a Younger Patient: A Case Report - Cureus
• Expanding options for perihilar cholangiocarcinoma - mayoclinic.org
• Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study - Nature
• LncRNA PVT1 promotes proliferation, migration and invasion of cholangiocarcinoma by regulating the expression of SOCS2 - Nature
• Zenocutuzumab‑zbco Secures FDA Orphan Drug Designation in NRG1 Fusion–Positive Cholangiocarcinoma - Oncodaily
• Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma - The New England Journal of Medicine
• Genfit reports promising phase 1b data in cholangiocarcinoma - PharmaTimes
• Ivosidenib Has Preliminary Real-World Activity in IDH1-Mutated Cholangiocarcinoma - OncLive
• Cholangiocarcinoma Foundation Annual Conference 2026 - Oncodaily
• China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma - OncLive
• Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial - Cleveland Clinic
• Targeting the gut-liver axis in cholangiocarcinoma: mechanisms, therapeutic advances, and future directions - Frontiers
• Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potential of Zenocutuzumab-zbco in NRG1+ Cholangiocarcinoma to be Presented at AACR-NCI-EORTC - PR Newswire
• Cholangiocarcinoma: Is Preoperative Histologic Confirmation Mandatory Before Major Hepatobiliary Surgery? - Cureus
• FDA Grants Breakthrough Therapy Designation to Zenocutuzumab in NRG1+ Cholangiocarcinoma - OncLive
• Microwave Ablation vs Repeat Liver Resection in Intrahepatic Cholangiocarcinoma | Radiology In A Minute - RSNA Journals
• Prognostic value of preoperative serum ferritin in cholangiocarcinoma patients - Nature
• Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives - Frontiers
• IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts | British Journal of Cancer - Nature
• A Scoring System for Risk Stratification in Intrahepatic Cholangiocarcinoma after Immunotherapy - RSNA Journals
• Case 1: Metastatic Cholangiocarcinoma - The ASCO Post
• City of Springfield observes its first Cholangiocarcinoma Awareness Month - wwlp.com
• Association of biliary microflora dysbiosis with cholangiocarcinoma: a single-center study - Frontiers
• Perihilar Extrahepatic Cholangiocarcinoma With Typical and Atypical Manifestations: Diagnostic Resolution During Autopsy - Cureus
• 68Ga-FAPI-46 PET/CT in Primary Sclerosing Cholangitis and Suspected Cholangiocarcinoma - jnm.snmjournals.org
• Tinengotinib in Previously Treated Cholangiocarcinoma: New Signals from a Multicentre Phase 2 Trial - Oncodaily
• Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression - Nature
• Targeted Therapies Offer Hope for Cholangiocarcinoma - Targeted Oncology
• Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma - Nature
• Adjuvant Camrelizumab Plus Capecitabine in Intrahepatic Cholangiocarcinoma After Surgical Resection: Chinese Phase 2 Trial - Oncodaily
• Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinoma - Nature
• Lindsey: Cholangiocarcinoma research needs bold investment now - The Detroit News
• Successful Treatment of BRAF V600E-Mutant Intrahepatic Cholangiocarcinoma With Encorafenib, Binimetinib, and Cetuximab - Cureus
• 68Ga-FAPI-46 PET/CT in Primary Sclerosing Cholangitis and Suspected Cholangiocarcinoma - jnm.snmjournals.org
• Hepatic Duct Foreign Body Mimicking Cholangiocarcinoma: Case Analysis, Diagnostic Challenges, and Literature Review - Cureus
• Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment - Frontiers
• Radiation Therapy Boosts Outcomes for Huge Bile Tumors - National Today
• A Global Collaborative Forum on Cholangiocarcinoma – Jarurat Care Foundation - Oncodaily
• Laparoscopic hepaticopancreaticoduodenectomy for synchronous intrahepatic cholangiocarcinoma and distal common bile duct tumors: a case report - Frontiers
• Tinengotinib Shows Activity in Previously Treated FGFR-Altered Cholangiocarcinoma - EMJ
• FDA Grants Breakthrough Therapy Designation to Zenocutuzumab-zbco for NRG1-Positive Cholangiocarcinoma - Oncodaily
• Single-cell transcriptome sequencing reveals tumor stem cells and their molecular characteristics in intrahepatic cholangiocarcinoma - Nature
• Editorial: Innovative approaches to cholangiocarcinoma: diagnosis, treatment, and multidisciplinary care - Frontiers
• Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context - Frontiers
• Cancer-associated fibroblasts in cholangiocarcinoma: the central nexus of tumor-stroma crosstalk and therapeutic translation - Frontiers
• Conversion Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study - Wiley Online Library
• Characteristics of “Very Early” Intrahepatic Cholangiocarcinoma Undergoing Liver Resection and Its Relationship With Carbohydrate Antigen 19-9 - Wiley Online Library
• Call to improve survival rates for bile duct cancer patients | UCL News - UCL - University College London
• Vilma Pacheco Barcia: Late Diagnosis of Cholangiocarcinoma Makes Outcomes More Uncertain - Oncodaily
• Combination therapy sets new survival standard for advanced biliary tract cancer - News-Medical
• A case report of a rare intrahepatic cholangiocarcinoma with rectal metastasis - Frontiers
• Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment - The Manila Times
• Cholangiocarcinoma, a rare cancer of the bile duct - Servier
• Finding a rare bile duct cancer’s weaknesses - Fred Hutchinson Cancer Center
• James J Harding: Excellent Editorial on HER2 Directed Therapy in Patients with Biliary Tract Cancer - Oncodaily
• NHS urged to approve new treatment for aggressive cancer after tumours shrink in size - The Independent
• For overlooked cholangiocarcinoma patients, there’s a light at the end of the tunnel - Fred Hutchinson Cancer Center
• Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma - Frontiers
• Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians - Wiley
• Progress in Radiotherapy for Cholangiocarcinoma - Frontiers
• Prognostic factors in patients with intrahepatic cholangiocarcinoma - Nature
• Diagnostic cholangioscopy for surgical planning of extrahepatic cholangiocarcinoma - Nature
• Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance - Nature